GlycoMimetics Statistics
Total Valuation
GlycoMimetics has a market cap or net worth of $15.08 million. The enterprise value is $953,267.
Important Dates
The next estimated earnings date is Monday, January 6, 2025, after market close.
Earnings Date | Jan 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
GlycoMimetics has 64.48 million shares outstanding. The number of shares has increased by 6.56% in one year.
Current Share Class | 64.48M |
Shares Outstanding | 64.48M |
Shares Change (YoY) | +6.56% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 3.15% |
Owned by Institutions (%) | 13.22% |
Float | 42.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.33 |
P/TBV Ratio | 1.33 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 95.33 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.02.
Current Ratio | 3.62 |
Quick Ratio | 3.34 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -137.20% and return on invested capital (ROIC) is -77.67%.
Return on Equity (ROE) | -137.20% |
Return on Assets (ROA) | -66.74% |
Return on Capital (ROIC) | -77.67% |
Revenue Per Employee | $286 |
Profits Per Employee | -$1.14M |
Employee Count | 35 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.02% in the last 52 weeks. The beta is 1.78, so GlycoMimetics's price volatility has been higher than the market average.
Beta (5Y) | 1.78 |
52-Week Price Change | -89.02% |
50-Day Moving Average | 0.30 |
200-Day Moving Average | 0.68 |
Relative Strength Index (RSI) | 39.45 |
Average Volume (20 Days) | 1,096,891 |
Short Selling Information
The latest short interest is 2.60 million, so 4.03% of the outstanding shares have been sold short.
Short Interest | 2.60M |
Short Previous Month | 3.80M |
Short % of Shares Out | 4.03% |
Short % of Float | 6.07% |
Short Ratio (days to cover) | 1.07 |
Income Statement
In the last 12 months, GlycoMimetics had revenue of $10,000 and -$39.74 million in losses. Loss per share was -$0.62.
Revenue | 10,000 |
Gross Profit | 10,000 |
Operating Income | -36.78M |
Pretax Income | -39.11M |
Net Income | -39.74M |
EBITDA | -36.73M |
EBIT | -36.78M |
Loss Per Share | -$0.62 |
Full Income Statement Balance Sheet
The company has $14.39 million in cash and $262,133 in debt, giving a net cash position of $14.13 million or $0.22 per share.
Cash & Cash Equivalents | 14.39M |
Total Debt | 262,133 |
Net Cash | 14.13M |
Net Cash Per Share | $0.22 |
Equity (Book Value) | 11.38M |
Book Value Per Share | 0.18 |
Working Capital | 11.32M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$35.01 million and capital expenditures -$10,773, giving a free cash flow of -$35.02 million.
Operating Cash Flow | -35.01M |
Capital Expenditures | -10,773 |
Free Cash Flow | -35.02M |
FCF Per Share | -$0.54 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -367,847.59% |
Pretax Margin | -397,350.46% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GlycoMimetics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.56% |
Shareholder Yield | -6.56% |
Earnings Yield | -263.45% |
FCF Yield | -232.20% |
Analyst Forecast
The average price target for GlycoMimetics is $12.00, which is 5,030.40% higher than the current price. The consensus rating is "Hold".
Price Target | $12.00 |
Price Target Difference | 5,030.40% |
Analyst Consensus | Hold |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
GlycoMimetics has an Altman Z-Score of -37.52 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -37.52 |
Piotroski F-Score | 1 |